Scientists at CU Anschutz are launching the Vanguard Study, using a new blood test designed to detect multiple types of cancer before traditional screenings can.
Researchers at the CU Anschutz Cancer Center have launched a clinical trial funded by the National Cancer Institute that will ...
James van der Beek shared the overlooked warning sign of his stage 3 colon cancer and why early screening at 45 is crucial.
COLORECTAL CANCER IS THE SECOND LEADING CAUSE OF CANCER RELATED DEATHS IN LOUISIANA, AND NOW A WELL KNOWN ACTOR IS URGING ALL IN T ...
The University of Colorado Cancer Center at CU Anschutz has been selected by the National Cancer Institute as one of just ...
Morning Overview on MSN
New blood markers may spot early-onset pancreatic cancer before symptoms hit
Pancreatic ductal adenocarcinoma is one of the most lethal cancers, in large part because it usually stays hidden until it ...
Research shows these test often find something, but much less often find actual disease. One study in 2020 found that 95% of ...
Australian scientists have discovered that DNA barcoding can be used to track cancer cells in solid and liquid biopsies, empowering future research into more reliable breast cancer diagnosis and ...
Australian scientists have discovered that DNA barcoding can be used to track cancer cells in solid and liquid biopsies, empowering future research into more reliable breast cancer diagnosis and ...
Vocxi Health is closer than ever to launching a handheld breath test that uses graphene nanosensors to detect asymptomatic cancer.
While the method shows promise, some experts say that other self-collection devices are more readily available ...
You can take actions to help protect yourself from cancer—and your state can too with systematic interventions, such as policies, programs, and educational campaigns, to reduce cancer risk factors and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results